|
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) is set to host a crucial seminar on “Market Access Issues for Export of Pharmaceutical Products & Implication on MSMEs - Post Budget Announcement” on February 21, 2025 in Mumbai. The seminar will serve as a key platform for industry stakeholders to discuss pressing challenges and opportunities in pharmaceutical exports following the recent Union Budget announcement.
The event will feature high-profile discussions on tariff and non-tariff barriers, regulatory concerns, and policy developments affecting the pharmaceutical sector. Experts from the Directorate General of Foreign Trade (DGFT), Customs, GST authorities, and Central and State Drug Regulatory bodies will address the gathering, offering insights on evolving regulations and compliance frameworks.
Pharmexcil, the premier body responsible for promoting pharmaceutical exports from India, has been instrumental in addressing trade-related concerns and facilitating global market access for Indian pharmaceutical companies. Highlighting the council’s proactive role, Raja Bhanu K, director general of Pharmexcil, stated, “The pharmaceutical sector is a cornerstone of India’s global trade, and ensuring seamless export mechanisms is crucial for its growth. This seminar aims to equip exporters, especially MSMEs, with knowledge on regulatory changes and market access strategies post-budget. We encourage all member companies to participate and leverage this opportunity to engage directly with policymakers and experts.”
The seminar will take place at Onyx Hall, IRA by Orchid Hotel, Andheri, from 3:30 pm to 6:00 pm. Member companies are urged to confirm their participation by registering via the following link: https://bit.ly/4jXTdUQ.
With a robust agenda and the presence of esteemed speakers, this seminar is expected to provide valuable takeaways for industry players navigating the evolving pharmaceutical export landscape. Pharmexcil remains committed to empowering exporters and strengthening India’s position in the global pharmaceutical market.
|